Cargando…
Commercial Scale Manufacturing of Allogeneic Cell Therapy
Allogeneic cell therapy products are generating encouraging clinical and pre-clinical results. Pluripotent stem cell (PSC) derived therapies, in particular, have substantial momentum and the potential to serve as treatments for a wide range of indications. Many of these therapies are also expected t...
Autores principales: | Pigeau, Gary M., Csaszar, Elizabeth, Dulgar-Tulloch, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113399/ https://www.ncbi.nlm.nih.gov/pubmed/30186836 http://dx.doi.org/10.3389/fmed.2018.00233 |
Ejemplares similares
-
Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges
por: Iyer, Rohin K., et al.
Publicado: (2018) -
Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
por: Lee, Brian, et al.
Publicado: (2020) -
Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
por: Lee, Brian, et al.
Publicado: (2022) -
Ex vivo Manufactured Neutrophils for Treatment of Neutropenia—A Process Economic Evaluation
por: Torres-Acosta, Mario A., et al.
Publicado: (2019) -
The Upscale Manufacture of Chondrocytes for Allogeneic Cartilage Therapies
por: Hulme, Charlotte H., et al.
Publicado: (2023)